Trials / Unknown
UnknownNCT02934815
Relational and Emotional Mechanisms of a Supportive-expressive Group Intervention in Breast Cancer
Relational and Emotional Mechanisms of a Supportive-expressive Group Intervention (SEGT) for Women With Breast Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Universidade do Porto · Academic / Other
- Sex
- Female
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To test the feasibility of supportive-expressive group intervention (SEGT) for women with primary breast cancer and to provide a preliminary test of its efficacy.
Detailed description
This study aims to compare the efficacy of a 16-sessions group intervention (Supportive-Expressive group therapy) versus control group (no intervention) in women with primary breast cancer. This study tries to evaluate the efficacy of SEGT on breast cancer patients' emotion regulation, social support, caregiving, and marital satisfaction, and its improvement on breast cancer patients' life quality. This study also intents to explore the moderating role of attachment on these associations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Supportive-expressive group therapy | The supportive-expressive group therapy (SEGT) is an intervention for women with BC that is designed to build bonds and to facilitate changes in emotional expression and regulation taking into account the role that emotions play in physiologic function, intimately related to the progression of the disease. It is based on seven main themes: building bonds, expressing feelings, detoxifying dying, reordering life priorities, improve support from and communication with family and friends, fortifying families, dealing with doctors, and control pain and anxiety. Although originally developed according to an existential perspective, recently the supportive-expressive group therapy has been used according to an attachment framework. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2016-10-17
- Last updated
- 2016-10-17
Locations
1 site across 1 country: Portugal
Source: ClinicalTrials.gov record NCT02934815. Inclusion in this directory is not an endorsement.